Awareness survey of parties involved in pharmacogenomics in Japan

Pharmacogenomics

Volumn 8, Issue 3, 2007, Pages 275-286

  Tamaoki, Mieko ^a   Gushima, Hiroshi ^b   Tsutani, Kiichiro ^c  

^a ASTELLAS PHARMA INC   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Awareness survey; Companies; Health professionals; Japan pharmacogenomics

Indexed keywords

DRUG;

ACCESS TO INFORMATION; ARTICLE; AWARENESS; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; GOVERNMENT; HEALTH CARE INDUSTRY; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HUMAN; INDIVIDUALIZATION; JAPAN; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIETY; METHODOLOGY; NEEDS ASSESSMENT; PATIENT INFORMATION; PHARMACOGENOMICS; POSTMARKETING SURVEILLANCE; PREVENTIVE MEDICINE; PUBLISHING; QUESTIONNAIRE;

AWARENESS; DATA COLLECTION; DRUG INDUSTRY; HEALTH CARE SECTOR; HEALTH PERSONNEL; HUMANS; JAPAN; PHARMACOGENETICS;

EID: 33947585095     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.3.275     Document Type: Article

References (10)

1. Sumino Y, Miyagijima T. Research on pharmacokinetic-related genetic polymorphisms in Japanese. Establishment of Pharma SNP Consortium (PSC) by Japan Pharmaceutical Manufacturers Association. Faruaw 35(12), 1086 (2000).
2. Japan Health Sciences Foundation: Survey and Prospective Researh Project Report (Survey on Batic Technology in Japan) - Prospects for Medical Needs in 2010. Tokyo, Japan (2001).
3. Japan Health Sciences Foundation: Survey Report: Toward Clinical Application of Genomics. Tokyo, Japan (2003).
4. Japan Health Sciences Foundation: Regulatory Trends Survey Report Prospects for Regulatory Science: Discussions and Proposals Based on Questionnaire Survey. Tokyo, Japan (2006).
5. Japan Health Sciences Foundation: Survey and Prospective Research Project Report (Survey on Basic Technology in Japan) - Prospects for Medical Needs in 2015. Tokyo (2006).
6. Melzer D, Raven A, Detmer DE, Ling T, Zimmern RL: My Very Own Medicine What Must I Know? Information Policy for Pharmacogenetics. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (2003).
7. Hopkins MM, Ibarreta D, Gaisser S et al: Putting pharmacogenetics into practice. Nat. Biotech. 24, 403-410 (2006).
8. Nuffield Council on Bioethics: Pharmacogenetics: Ethical Issues. Bob Hepple (Chair), Nuffield Council, London, UK (2003)
9. Royal Society: Personalized Medicines: Hopes and Realities. David Weatherall (Chair), Royal Society, London, UK (2005).
10. Ministry of Health, Labour and Welfare: Submission of Information to Regulatory Authorities for Preparation at Guidance for the Use of Pharmacogenomics in Clinical Trials. (2005).